MKC Quote, Financials, Valuation and Earnings

Colgate-Palmolive has a net margin of 10.11% compared to McCormick &'s net margin of 14.94%. McCormick &'s return on equity of 14.63% beat Colgate-Palmolive's return on equity of 420.55%.

McCormick & has a consensus price target of $83.27, signalling upside risk potential of 13.24%. On the other hand Colgate-Palmolive has an analysts' consensus of $97.54 which suggests that it could grow by 4.34%. Given that McCormick & has higher upside potential than Colgate-Palmolive, analysts believe McCormick & is more attractive than Colgate-Palmolive.

McCormick & has a beta of 0.751, which suggesting that the stock is 24.856% less volatile than S&P 500. In comparison Colgate-Palmolive has a beta of 0.402, suggesting its less volatile than the S&P 500 by 59.762%.

McCormick & has a quarterly dividend of $0.45 per share corresponding to a yield of 2.37%. Colgate-Palmolive offers a yield of 2.14% to investors and pays a quarterly dividend of $0.52 per share. McCormick & pays 57.2% of its earnings as a dividend. Colgate-Palmolive pays out 61.93% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

McCormick & quarterly revenues are $1.6B, which are smaller than Colgate-Palmolive quarterly revenues of $4.9B. McCormick &'s net income of $162.3M is lower than Colgate-Palmolive's net income of $739M. Notably, McCormick &'s price-to-earnings ratio is 25.27x while Colgate-Palmolive's PE ratio is 26.56x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McCormick & is 2.95x versus 3.83x for Colgate-Palmolive. Usually stocks with elevated PS ratios are considered overvalued.

Interparfums has a net margin of 10.11% compared to McCormick &'s net margin of 6.7%. McCormick &'s return on equity of 14.63% beat Interparfums's return on equity of 17.75%.

McCormick & has a consensus price target of $83.27, signalling upside risk potential of 13.24%. On the other hand Interparfums has an analysts' consensus of $169.75 which suggests that it could grow by 65.69%. Given that Interparfums has higher upside potential than McCormick &, analysts believe Interparfums is more attractive than McCormick &.

McCormick & has a beta of 0.751, which suggesting that the stock is 24.856% less volatile than S&P 500. In comparison Interparfums has a beta of 1.153, suggesting its more volatile than the S&P 500 by 15.259%.

McCormick & has a quarterly dividend of $0.45 per share corresponding to a yield of 2.37%. Interparfums offers a yield of 2.98% to investors and pays a quarterly dividend of $0.80 per share. McCormick & pays 57.2% of its earnings as a dividend. Interparfums pays out 58.43% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

McCormick & quarterly revenues are $1.6B, which are larger than Interparfums quarterly revenues of $361.5M. McCormick &'s net income of $162.3M is higher than Interparfums's net income of $24.2M. Notably, McCormick &'s price-to-earnings ratio is 25.27x while Interparfums's PE ratio is 20.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McCormick & is 2.95x versus 2.27x for Interparfums. Usually stocks with elevated PS ratios are considered overvalued.

Kimberly-Clark has a net margin of 10.11% compared to McCormick &'s net margin of 9.07%. McCormick &'s return on equity of 14.63% beat Kimberly-Clark's return on equity of 213.79%.

McCormick & has a consensus price target of $83.27, signalling upside risk potential of 13.24%. On the other hand Kimberly-Clark has an analysts' consensus of $144.99 which suggests that it could grow by 3.79%. Given that McCormick & has higher upside potential than Kimberly-Clark, analysts believe McCormick & is more attractive than Kimberly-Clark.

McCormick & has a beta of 0.751, which suggesting that the stock is 24.856% less volatile than S&P 500. In comparison Kimberly-Clark has a beta of 0.376, suggesting its less volatile than the S&P 500 by 62.423%.

McCormick & has a quarterly dividend of $0.45 per share corresponding to a yield of 2.37%. Kimberly-Clark offers a yield of 3.52% to investors and pays a quarterly dividend of $1.26 per share. McCormick & pays 57.2% of its earnings as a dividend. Kimberly-Clark pays out 63.97% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

McCormick & quarterly revenues are $1.6B, which are smaller than Kimberly-Clark quarterly revenues of $4.9B. McCormick &'s net income of $162.3M is lower than Kimberly-Clark's net income of $447M. Notably, McCormick &'s price-to-earnings ratio is 25.27x while Kimberly-Clark's PE ratio is 18.50x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McCormick & is 2.95x versus 2.35x for Kimberly-Clark. Usually stocks with elevated PS ratios are considered overvalued.

Procter & Gamble has a net margin of 10.11% compared to McCormick &'s net margin of 21.16%. McCormick &'s return on equity of 14.63% beat Procter & Gamble's return on equity of 30.56%.

McCormick & has a consensus price target of $83.27, signalling upside risk potential of 13.24%. On the other hand Procter & Gamble has an analysts' consensus of $176.69 which suggests that it could grow by 6.31%. Given that McCormick & has higher upside potential than Procter & Gamble, analysts believe McCormick & is more attractive than Procter & Gamble.

McCormick & has a beta of 0.751, which suggesting that the stock is 24.856% less volatile than S&P 500. In comparison Procter & Gamble has a beta of 0.426, suggesting its less volatile than the S&P 500 by 57.448%.

McCormick & has a quarterly dividend of $0.45 per share corresponding to a yield of 2.37%. Procter & Gamble offers a yield of 2.42% to investors and pays a quarterly dividend of $1.01 per share. McCormick & pays 57.2% of its earnings as a dividend. Procter & Gamble pays out 62.59% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

McCormick & quarterly revenues are $1.6B, which are smaller than Procter & Gamble quarterly revenues of $21.9B. McCormick &'s net income of $162.3M is lower than Procter & Gamble's net income of $4.6B. Notably, McCormick &'s price-to-earnings ratio is 25.27x while Procter & Gamble's PE ratio is 26.50x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McCormick & is 2.95x versus 4.87x for Procter & Gamble. Usually stocks with elevated PS ratios are considered overvalued.